News briefing: Gyroscope and Talaris set IPO terms; FDA grants expanded nod to Chiesi's sickle cell drug
In a week where two biotech IPOs were already expected, another two prospective entrants have set their debut terms ahead of their launch later this …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
